Interleukin-10: A Key Cytokine in Depression?
Author(s) -
Susana Roque,
Margarida CorreiaNeves,
Ana Mesquita,
Joana Almeida Palha,
Nuno Sousa
Publication year - 2009
Publication title -
cardiovascular psychiatry and neurology
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.904
H-Index - 24
eISSN - 2090-0163
pISSN - 2090-0171
DOI - 10.1155/2009/187894
Subject(s) - proinflammatory cytokine , cytokine , depression (economics) , antidepressant , notice , medicine , interleukin 6 , immunology , psychiatry , bioinformatics , inflammation , anxiety , biology , political science , economics , law , macroeconomics
An increasing body of evidence implicates proinflammatory cytokines in psychiatric disorders, namely, in depression. Of notice, recent studies showed that anti-inflammatory cytokines, such as IL-10, also modulate depressive-like behavior. In this article, we propose that the anti-inflammatory cytokine IL-10 is a putative link between two of the most widely reported phenomenon observed in depressed patients: the disruption of the hypothalamic-pituitary-adrenal axis and the imbalanced production of cytokines. If so, IL-10 might represent a novel target for antidepressant therapy.
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom